Transcription of HIV-1 at sites of intact latent provirus integration.


Journal

The Journal of experimental medicine
ISSN: 1540-9538
Titre abrégé: J Exp Med
Pays: United States
ID NLM: 2985109R

Informations de publication

Date de publication:
02 Sep 2024
Historique:
received: 01 03 2024
revised: 21 05 2024
accepted: 30 07 2024
medline: 14 8 2024
pubmed: 14 8 2024
entrez: 14 8 2024
Statut: ppublish

Résumé

HIV-1 antiretroviral therapy is highly effective but fails to eliminate a reservoir of latent proviruses, leading to a requirement for life-long treatment. How the site of integration of authentic intact latent proviruses might impact their own or neighboring gene expression or reservoir dynamics is poorly understood. Here, we report on proviral and neighboring gene transcription at sites of intact latent HIV-1 integration in cultured T cells obtained directly from people living with HIV, as well as engineered primary T cells and cell lines. Proviral gene expression was correlated to the level of endogenous gene expression under resting but not activated conditions. Notably, latent proviral promoters were 100-10,000× less active than in productively infected cells and had little or no measurable impact on neighboring gene expression under resting or activated conditions. Thus, the site of integration has a dominant effect on the transcriptional activity of intact HIV-1 proviruses in the latent reservoir, thereby influencing cytopathic effects and proviral immune evasion.

Identifiants

pubmed: 39141127
pii: 276907
doi: 10.1084/jem.20240391
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIH HHS
ID : UM1 AI100663
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI164565
Pays : United States
Organisme : Einstein-Rockefeller-CUNY Center for AIDS Research
ID : 1P30AI124414-01A1
Organisme : NIAID NIH HHS
ID : UM1 AI126620
Pays : United States
Organisme : Bill & Melinda Gates Foundation
ID : INV-002705
Pays : United States
Organisme : Stavros Niarchos Foundation
Organisme : Rockefeller University

Informations de copyright

© 2024 Teixeira et al.

Auteurs

Ana Rafaela Teixeira (AR)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.

Cintia Bittar (C)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.

Gabriela S Silva Santos (GS)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.

Thiago Y Oliveira (TY)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.

Amy S Huang (AS)

Tessera Therapeutics , Somerville, MA, USA.

Noemi Linden (N)

Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

Isabella A T M Ferreira (IATM)

Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

Tetyana Murdza (T)

Department of Infectious Diseases, Medical Faculty Heidelberg, Virology, Center for Integrative Infectious Disease Research (CIID), Heidelberg University, Heidelberg, Germany.

Frauke Muecksch (F)

Department of Infectious Diseases, Medical Faculty Heidelberg, Virology, Center for Integrative Infectious Disease Research (CIID), Heidelberg University, Heidelberg, Germany.
Department of Infectious Diseases, Virology, Chica and Heinz Schaller (CHS) Research Group, University Hospital Heidelberg, Heidelberg, Germany.

R Brad Jones (RB)

Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

Marina Caskey (M)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.

Mila Jankovic (M)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.

Michel C Nussenzweig (MC)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.
Howard Hughes Medical Institute , Chevy Chase, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH